C

Cooper Companies Inc
LSE:0I3I

Watchlist Manager
Cooper Companies Inc
LSE:0I3I
Watchlist
Price: 94.41 USD 3.01% Market Closed
Market Cap: 468.2B USD
Have any thoughts about
Cooper Companies Inc?
Write Note

Cooper Companies Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Cooper Companies Inc
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
C
Cooper Companies Inc
BMV:COO
Revenue
$3.9B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
9%
Haemonetics Corp
NYSE:HAE
Revenue
$1.4B
CAGR 3-Years
13%
CAGR 5-Years
7%
CAGR 10-Years
4%
ICU Medical Inc
NASDAQ:ICUI
Revenue
$2.3B
CAGR 3-Years
22%
CAGR 5-Years
13%
CAGR 10-Years
23%
Align Technology Inc
NASDAQ:ALGN
Revenue
$4B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
18%
Lantheus Holdings Inc
NASDAQ:LNTH
Revenue
$1.5B
CAGR 3-Years
57%
CAGR 5-Years
34%
CAGR 10-Years
18%
Merit Medical Systems Inc
NASDAQ:MMSI
Revenue
$1.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
10%
No Stocks Found

Cooper Companies Inc
Revenue Breakdown

Breakdown by Geography
Cooper Companies Inc

Total Revenue: 3.9B USD
100%
United States: 1.8B USD
46.5%
Europe: 1B USD
26.7%
Rest Of World: 739.8m USD
19%

Breakdown by Segments
Cooper Companies Inc

Total Revenue: 3.9B USD
100%
Coopervision: 2.4B USD
62.2%
Coopersurgical: 1.2B USD
30%
Toric Lens: 828.7m USD
21.3%
Single-Use Sphere Lens: 705.4m USD
18.1%
Office And Surgical: 689.5m USD
17.7%
Non Single-Use Sphere, Other: 583.9m USD
15%
Fertility: 480m USD
12.3%
Multifocal Lens: 305.7m USD
7.8%
Show More
Show Less

Cooper Companies Inc
Glance View

Market Cap
468.2B USD
Industry
Health Care

In the world of healthcare innovation, Cooper Companies Inc. etched its name as a significant player, specializing in creating products that enhance lives, particularly in the fields of vision care and women’s health. Established in 1958, Cooper Companies evolved to become a holding company operating through its two primary business units: CooperVision and CooperSurgical. CooperVision is renowned globally for its expertise in contact lenses, providing a diversified range of lenses to correct myopia, hyperopia, astigmatism, and presbyopia. By leveraging cutting-edge technology and a deep understanding of wearer needs, CooperVision caters to a wide spectrum of users, from daily disposables to specialty lenses, thus driving consistent revenue through the consumable nature of its products. CooperSurgical, on the other hand, focuses on solutions for women’s health, offering a gamut of medical instruments, devices, and diagnostics. This unit extends Cooper Companies' footprint into the realms of fertility products, contraception, and obstetrics. By addressing key segments of the women’s health market, CooperSurgical supports clinical needs across a woman’s lifespan. Revenue opportunities here arise from both its durable medical equipment and consumable products, which ensure a stream of repeat business as healthcare providers replenish their supplies. Together, these divisions enable Cooper Companies to not only secure a robust market position but also continuously explore new areas for growth and expansion within the broader healthcare industry.

0I3I Intrinsic Value
696.37 USD
Undervaluation 86%
Intrinsic Value
Price
C

See Also

What is Cooper Companies Inc's Revenue?
Revenue
3.9B USD

Based on the financial report for Oct 31, 2024, Cooper Companies Inc's Revenue amounts to 3.9B USD.

What is Cooper Companies Inc's Revenue growth rate?
Revenue CAGR 10Y
9%

Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Cooper Companies Inc have been 10% over the past three years , 8% over the past five years , and 9% over the past ten years .

Back to Top